ICVTS Click here to go to Siemens website
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Interact CardioVasc Thorac Surg 2008;7:106. doi:10.1510/icvts.2007.166322B
© 2008 European Association of Cardio-Thoracic Surgery

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Seiki Hasegawa
Right arrow Permission Requests
Google Scholar
Right arrow Articles by Hasegawa, S.
PubMed
Right arrow Articles by Hasegawa, S.
Related Collections
Right arrowRelated Article

eComment

EPP and P/D: which to choose?

Seiki Hasegawa

Hyogo College of Medicine, 1-1 Mukogawa-cho, Nishinomiya 663-8501, Japan

Radical surgery for malignant pleural mesothelioma: results and prognosis

I read with great interest the article by Okada and others [1]. I believe that this article represents the state of the art of surgical treatment for malignant plural mesothelioma (MPM) in Japan, not only because this is Japan's largest series famous for close collaboration of MPM experts.

In the present study, there was no significant difference of survival between extrapleural pneumonectomy (EPP) and pleurectomy/decortication (P/D). Okada interprets that the result reflects relatively early stage disease and predominant epithelial histology in P/D group. However, a similar result has been reported from Memorial Sloan-Kettering Cancer Center Group [2], where more than half of the patients were belonging to unclassified histology and staging information was missing in almost half of the patients. The above facts lead to a hypothesis that EPP and P/D might be equal in view of postoperative median survival. The possible mechanism is that severity of EPP may offset its curative power. If so, EPP should be indicated only for patients who seek for cure, not for extending survival with MPM.

It is still unsolved whether P/D is just a limited surgery for patients with poor surgical durability or not. I am interested in the authors' current policy for P/D.


    References
 Top
 References
 

  1. Okada M, Mimura T, Ohbayashi C, Sakuma T, Soejima T, Tsubota N. Radical surgery for malignant pleural mesothelioma: results and prognosis. Interact CardioVasc Thorac Surg 2008; 7:102–106.[Abstract/Free Full Text]
  2. Flores RM, Zakowski M, Venkatraman E, Krug L, Rosenzweig K, Dycoco J, Lee C, Yeoh C, Bains M, Rusch V. Prognostic factors in the treatment of malignant pleural mesothelioma at a large tertiary referral center. J Thorac Oncol 2007; 2:957–965.[Medline]

Related Article

Radical surgery for malignant pleural mesothelioma: results and prognosis
Morihito Okada, Takeshi Mimura, Chiho Ohbayashi, Toshiko Sakuma, Toshinori Soejima, and Noriaki Tsubota
Interactive CardioVascular and Thoracic Surgery 2008 7: 102-106. [Abstract] [Full Text] [PDF]




This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Seiki Hasegawa
Right arrow Permission Requests
Google Scholar
Right arrow Articles by Hasegawa, S.
PubMed
Right arrow Articles by Hasegawa, S.
Related Collections
Right arrowRelated Article


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS